Literature DB >> 2982555

Prognostic correlations of operable carcinoma of the rectum.

C A Carlon, G Fabris, C Arslan-Pagnini, A M Pluchinotta, E Chinelli, S Carniato.   

Abstract

Various histologic factors correlated to survival were studied in 124 patients radically operated on for rectal carcinoma in order to establish valid prognostic criteria. The total survival rate after five years was 63 percent, while in stage B1 it was 89 percent, in B2, 61 percent, and in C1, 47 percent (P less than 0.05). With regard to histotype, the survival was 83 percent in the papillary subtype of adenocarcinoma, while in the tubular subtype it was 62 percent, and 29 percent in the mucinous type (P = not significant). Vascular invasion negatively affected survival (41 percent); however, when there was no invasion, the prognosis was better (71 percent) (P less than 0.01). In evaluating histologic grading and lymphoglandular reactivity, the difference in survival rates was not statistically significant. The marked peri- and intratumoral lymphocytic infiltration gave a very good prognosis (92 percent) contrary to when reactivity was moderate (59 percent) or even absent (51 percent) (P less than 0.01). Finally, the expanding type tumor, with reference to Ming's classification of gastric carcinoma, had a much better prognosis (75 per cent) than the infiltrative type (40 percent) (P less than 0.01).

Entities:  

Mesh:

Year:  1985        PMID: 2982555     DOI: 10.1007/bf02553907

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Proliferation of T-cell subsets that contact tumour cells in colorectal cancer.

Authors:  S J C Golby; C Chinyama; J Spencer
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 3.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Lymphocytic infiltration and survival in rectal cancer.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

5.  Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma?

Authors:  B F Banner; J E Tomas-De La Vega; D L Roseman; J S Coon
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

Review 6.  Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

Authors:  Xiao-Feng Sun; Hong Zhang
Journal:  Mol Cancer       Date:  2006-10-06       Impact factor: 27.401

7.  Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion.

Authors:  T Kanai; M Watanabe; A Hayashi; A Nakazawa; T Yajima; A Okazawa; M Yamazaki; H Ishii; T Hibi
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

8.  Role of biological markers in the clinical outcome of colon cancer.

Authors:  O Nanni; A Volpi; G L Frassineti; F De Paola; A M Granato; A Dubini; W Zoli; E Scarpi; D Turci; G Oliverio; A Gambi; D Amadori
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

9.  Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.

Authors:  B Stein; F Momburg; V Schwarz; P Schlag; G Moldenhauer; P Möller
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.